84% of NET patients
Their needs for information about treatment
options were not met at the time of diagnosis.
58% of NET patients are
diagnosed at an advanced stage
How Can I Help?
CNETS is committed to improving the quality of life and survival for neuroendocrine (NET) cancer patients across Canada and in support of this vision introduced a new Research Funding Framework in 2016. The NET Cancer Research Grants provide grant-in-aid for NET...
This month NeuroEndocrine Cancer Australia joined forces with 13 other cancer organizations across Australia, to create one unified voice in the New Normal, Same Cancer campaign, to encourage Australians with unexplained symptoms to #GetChecked. In this powerful...
The European Cancer Summit is an annual event during which the European Cancer Organisation (E.C.O.) brings together leading oncology experts, experienced patient advocates, key opinion leaders, policy makers and politicians to discuss key issues in reducing the...